MedPath

Behavioral and Educational Tools to Improve Epilepsy Care

Not Applicable
Completed
Conditions
Epilepsy
Interventions
Other: Usual Care
Behavioral: Management of Risks in Epilepsy (MORE)
Other: Educational Materials
Behavioral: Telephone-based motivational interviewing (MORE+MI)
Registration Number
NCT02646631
Lead Sponsor
NYU Langone Health
Brief Summary

The long-term goal of this research is to improve seizure control among patients with epilepsy, which has the potential to improve quality of life for thousands of people living with epilepsy and reduce health care utilization, social and economic costs, and epilepsy-related mortalities. Participants who are suffering from epilepsy will be randomized to receive usual care (UC), a smartphone-based self-management intervention called Management of Risks in Epilepsy (MORE), or MORE + telephone-based motivational interviewing (MI). Participants will be followed for 3 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  1. At least 18 years of age
  2. English- or Spanish-speaking
  3. Partial (focal) or generalized epilepsy (as confirmed with epileptiform activity on an electroencephalogram)
  4. Poor medication adherence
  5. Willing and able to use a smartphone (provided by the study) to manage disease.
Read More
Exclusion Criteria
  1. Known or suspected psychogenic nonepileptic seizures as sole seizure type
  2. Active psychotic disorder
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MOREEducational Materials-
Usual TreatmentEducational Materials-
MOREUsual Care-
MOREManagement of Risks in Epilepsy (MORE)-
MORE + MIUsual Care-
MORE + MITelephone-based motivational interviewing (MORE+MI)-
Usual TreatmentUsual Care-
MORE + MIManagement of Risks in Epilepsy (MORE)-
MORE + MIEducational Materials-
Primary Outcome Measures
NameTimeMethod
Percent adherence to anti-epileptic drug schedule (pill counts)3 months
Secondary Outcome Measures
NameTimeMethod
Quality of life as measured by the PROMIS-10 questionnaire score3 months
Seizure frequency3 months
Quality of life as measured by the Quality of Life in Epilepsy questionnaire score3 months
Number of patients who complete the study3 months
Adherence to anti-epileptic drug schedule (self-reported) as measured by the Morisky Medication Adherence Scale3 months

As measured by the Morisky Medication Adherence Scale

Percentage of MI sessions completed3 months
Percentage of diary entries completed3 months

Trial Locations

Locations (1)

New York University School of Medicine

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath